Alzheimer’s & Dementia

Could regular daytime napping be a precursor to dementia — or even a sign that the disease has already taken hold? A new take on what has generally been considered a salutary practice creates some concerns, despite its caveats. I’m going to try not to lose any sleep over it.

Biogen, the maker of the controversial Alzheimer’s drug Aduhelm, last week released the long-awaited results of two clinical trials — which promptly raised more questions than they answered.

Concerned about my septuagenarian friend’s sudden memory lapse, I was comforted by new research suggesting that a little forgetfulness may not be a bad thing.

While the Medicare set awaits a final decision on coverage for Biogen’s controversial Alzheimer’s drug, a new study suggests seniors may get the same benefits from regular exercise. Both approaches, however, raise more questions than they answer.

While Alzheimer’s patients wait to see if Biogen’s new drug will someday prove effective — and affordable — researchers continue to make a case for the healing powers of meditation.

Raging wildfires and other sources of airborne pollution are threatening more than our respiratory and circulatory systems. New research is strengthening the link between air quality and dementia.